Innovotech's MBEC Assay Approved as International Biofilm Standard
Innovotech Inc., a pioneer in the field of biofilm product development, announces that its MBEC Assay has been approved as an ASTM International (ASTM) standard. The assay was validated for testing the effectiveness of hard-surface disinfectants formulated to kill biofilm. The MBEC Assay is a biofilm growth device, which allows for the rapid, reproducible and simultaneous evaluation of multiple test conditions against microorganisms in their natural, biofilm state.
"Currently, most disinfectants are evaluated using bacteria grown in suspension," says Dr. Darla M. Goeres, assistant research professor, Center for Biofilm Engineering (CBE) at Montana State University, and a member of the ASTM Subcommittee E35 on Pesticides, Antimicrobials, and Alternative Control Agents. "This method enables companies to determine the efficacy of products against bacteria in their more natural state, and therefore provides a better approach for predicting the efficacy of disinfectants under real-use conditions."
"The approval of the MBEC Assay as an ASTM standard represents a fundamental shift in how disinfectants will be evaluated on their effectiveness in protecting against harmful microorganisms," says Ken Boutilier, president and CEO of Innovotech. "This approval paves the way for a new generation of disinfectants in the food industry and in hospitals, designed specifically to address the issue of biofilms, thereby reducing the number of deaths and sicknesses resulting from foodborne and infection related illnesses."
Biofilms are organized communities of microorganisms that exist in virtually every natural environment. Biofilms can be up to 1000 times more resistant to treatment than the same organism in a free-floating state.
A recent report indicated that there are 76 million food-related illness a year, resulting in 325,000 hospitalizations and 5,000 deaths in the U.S., at a cost to the economy of $152 billion a year.
In addition to its MBEC Assay, Innovotech sells diagnostic kits that test bacterial susceptibility against antibiotics under biofilm conditions.
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.
